Conrad Stumpf

Conrad Stumpf

Haug Partners LLP

Contact
View Bio
RSS

Latest Posts › Intellectual Property Litigation

Share:

Defend & Deduct: How the Federal Circuit's Actavis Decision Changes Tax Implications for ANDA Filers

In Actavis Labs. FL, Inc. v. U.S.  (“Actavis”), a recent precedential decision, the Federal Circuit answered an important practical question regarding the interplay between the Hatch-Waxman Act and the Internal Revenue Code:...more

4/8/2025  /  Abbreviated New Drug Application (ANDA) , FDA Approval , Hatch-Waxman , Intellectual Property Litigation , Internal Revenue Code (IRC) , Patent Litigation , Pharmaceutical Industry , Pharmaceutical Patents , Tax Deductions , Tax Liability
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide